{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T00:51:17Z","timestamp":1723423877915},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,22]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Patch testing is an important investigation when dermatitis is unresponsive to, or worsened by, topical corticosteroid treatment. There is a balance to be struck between testing too many allergens, which is expensive, time consuming and risks causing sensitization, and testing too few, which risks missing the diagnosis. The current British Society for Cutaneous Allergy (BSCA) corticosteroid series comprises eight allergens and was last updated in February 2007.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To review and update the BSCA corticosteroid series.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively analysed data from 16 patch test centres in the UK and Ireland for all patients who were patch tested to a corticosteroid series between August 2017 and July 2019. We recorded the allergens tested, the number and percentage tested to a corticosteroid series and the number of positive results for each allergen. We identified the allergens that test positive in \u2265 0.1% of selectively tested patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, 3531 patients were tested to a corticosteroid series in the 16 centres. The number of allergens tested ranged from 7 to 18 (mean 10). The proportion of patch test patients who were tested to a corticosteroid series ranged from 1% to 99%. Six allergens in the 2017 BSCA series tested positive in \u2265 0.1% of patients. Nine allergens not in the BSCA corticosteroid series tested positive in \u2265 0.1% of patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This audit demonstrates the importance of regular review of recommended series and the significant variations in practice. The new BSCA corticosteroid series that we recommend contains 13 haptens, with the addition of the patient\u2019s own steroid creams as appropriate.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ced\/llac115","type":"journal-article","created":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T08:09:17Z","timestamp":1673165357000},"page":"339-344","source":"Crossref","is-referenced-by-count":1,"title":["Recommendation to update the British Society for Cutaneous Allergy corticosteroid series"],"prefix":"10.1093","volume":"48","author":[{"given":"Sarah E","family":"Morrow","sequence":"first","affiliation":[{"name":"Departments of Dermatology Oxford University Hospitals NHS Trust , Oxford , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanju","family":"Arianayagam","sequence":"additional","affiliation":[{"name":"Departments of Dermatology Oxford University Hospitals NHS Trust , Oxford , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Leeds Teaching Hospitals NHS Trust , Leeds , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Bourke","sequence":"additional","affiliation":[{"name":"South Infirmary Victoria University Hospital , Cork , Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandra Gooptu","family":"Bertram","sequence":"additional","affiliation":[{"name":"NHS Lothian , Edinburgh , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deirdre A","family":"Buckley","sequence":"additional","affiliation":[{"name":"Sulis Hospital , Bath , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahbub M U","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"University Hospital of Wales , Cardiff , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preshita","family":"Divekar","sequence":"additional","affiliation":[{"name":"Royal Cornwall Hospitals NHS Trust , Truro, Cornwall , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharizan Abdul","family":"Ghaffar","sequence":"additional","affiliation":[{"name":"Ninewells Hospital and Medical School , Dundee , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Green","sequence":"additional","affiliation":[{"name":"Ninewells Hospital and Medical School , Dundee , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Holden","sequence":"additional","affiliation":[{"name":"Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham A","family":"Johnston","sequence":"additional","affiliation":[{"name":"University Hospitals of Leicester NHS Trust , Leicester , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avad","family":"Mughal","sequence":"additional","affiliation":[{"name":"Swansea Bay University Health Board , Port Talbot , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eilis Nic","family":"Dhonncha","sequence":"additional","affiliation":[{"name":"South Infirmary Victoria University Hospital , Cork , Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Reckling","sequence":"additional","affiliation":[{"name":"East Kent Hospitals University NHS Foundation Trust , Canterbury , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krisztina","family":"Scharrer","sequence":"additional","affiliation":[{"name":"United Lincolnshire Hospitals NHS Trust , Lincoln , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Stone","sequence":"additional","affiliation":[{"name":"Aneurin Bevan University Health Board , Newport , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Thompson","sequence":"additional","affiliation":[{"name":"Sandwell and West Birmingham Hospitals NHS Trust , Birmingham , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Wakelin","sequence":"additional","affiliation":[{"name":"Imperial College Healthcare NHS Trust , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Cooper","sequence":"additional","affiliation":[{"name":"Departments of Dermatology Oxford University Hospitals NHS Trust , Oxford , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"key":"2023100315294772500_llac115-B1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.clindermatol.2010.11.007","article-title":"Effective prescribing in steroid allergy: controversies and cross-reactions","volume":"29","author":"Browne","year":"2011","journal-title":"Clin Dermatol"},{"key":"2023100315294772500_llac115-B2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/cod.12432","article-title":"European Society of Contact Dermatitis guideline for diagnostic patch testing \u2013 recommendations on best practice: ESCD patch test guideline","volume":"73","author":"Johansen","year":"2015","journal-title":"Contact Dermatitis"},{"key":"2023100315294772500_llac115-B3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-0536.1995.tb00535.x","article-title":"Screening for corticosteroid contact hypersensitivity","volume":"33","author":"Boffa","year":"1995","journal-title":"Contact Dermatitis"},{"key":"2023100315294772500_llac115-B4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/cod.12874","article-title":"Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study","volume":"78","author":"Mercader-Garc\u00eda","year":"2018","journal-title":"Contact Dermatitis"},{"key":"2023100315294772500_llac115-B5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0536.1999.tb06133.x","article-title":"Allergic contact dermatitis due to bendazac and alclometasone dipropionate","volume":"41","author":"Kana","year":"1999","journal-title":"Contact Dermatitis"},{"key":"2023100315294772500_llac115-B6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2340\/0001555575490493","article-title":"Contact allergy to topical corticosteroids and systemic contact dermatitis from prednisolone with tolerance of triamcinolone","volume":"75","author":"Bircher","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"2023100315294772500_llac115-B7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-0536.1998.tb05675.x","article-title":"Contact allergy to topical corticosteroids and systemic allergy to prednisolone","volume":"38","author":"McKenna","year":"1998","journal-title":"Contact Dermatitis"},{"key":"2023100315294772500_llac115-B8","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1365-2133.1995.tb00724.x","article-title":"Reactions to other corticosteroids in patients with allergic contact dermatitis from hydrocortisone","volume":"132","author":"Wilkinson","year":"1995","journal-title":"Br J Dermatol"},{"key":"2023100315294772500_llac115-B9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-0536.2011.01967.x","article-title":"Immediate and delayed allergic hypersensitivity to corticosteroids: practical guidelines","volume":"66","author":"Baeck","year":"2012","journal-title":"Contact Dermatitis"},{"key":"2023100315294772500_llac115-B10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2133.2003.05061.x","article-title":"Alternative glucocorticoids for use in cases of adverse reaction to systemic glucocorticoids: a study on 10 patients","volume":"148","author":"Ventura","year":"2003","journal-title":"Br J Dermatol"},{"key":"2023100315294772500_llac115-B11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-0536.1991.tb01809.x","article-title":"Hydrocortisone sensitivity: a prospective study of the value of tixocortol pivalate and hydrocortisone acetate as patch test markers","volume":"25","author":"Wilkinson","year":"1991","journal-title":"Contact Dermatitis"},{"key":"2023100315294772500_llac115-B12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/cod.12066","article-title":"Clinical relevance of tixocortol pivalate-positive patch tests and questionable bioequivalence of different hydrocortisone preparations","volume":"68","author":"Shaw","year":"2013","journal-title":"Contact Dermatitis"},{"key":"2023100315294772500_llac115-B13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1600-0536.2007.01136.x","article-title":"Tixocortol pivalate: what is the right concentration?","volume":"57","author":"Kalavala","year":"2007","journal-title":"Contact Dermatitis"},{"key":"2023100315294772500_llac115-B14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1600-0536.1996.tb02212.x","article-title":"Corticosteroid contact hypersensitivity: what vehicle and concentration?","volume":"34","author":"Wilkinson","year":"1996","journal-title":"Contact Dermatitis"},{"key":"2023100315294772500_llac115-B15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-2133.2002.04816.x","article-title":"Type-IV hypersensitivity to betamethasone valerate and clobetasol propionate: results of a multicentre study","volume":"147","author":"Sommer","year":"2002","journal-title":"Br J Dermatol"},{"key":"2023100315294772500_llac115-B16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-0536.1996.tb02226.x","article-title":"Fluticasone propionate and mometasone furoate have a low risk of contact sensitization","volume":"34","author":"Wilkinson","year":"1996","journal-title":"Contact Dermatitis"},{"key":"2023100315294772500_llac115-B17","first-page":"29","article-title":"Fluticasone propionate: a rare contact sensitizer","volume":"11","author":"Goossens","year":"2001","journal-title":"Eur J Dermatol"},{"key":"2023100315294772500_llac115-B18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0536.1995.tb00447.x","article-title":"Fluticasone propionate sensitivity in a patient with contact allergy to multiple corticosteroids","volume":"33","author":"Venning","year":"1995","journal-title":"Contact Dermatitis"},{"key":"2023100315294772500_llac115-B19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1001\/archderm.1978.01640130079025","article-title":"Contact dermatitis due to multiple corticosteroid creams","volume":"114","author":"Coskey","year":"1978","journal-title":"Arch Dermatol"},{"key":"2023100315294772500_llac115-B20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0536.1999.tb06252.x","article-title":"Allergic contact dermatitis from 1,2,6-hexanetriol in fluocinonide cream","volume":"41","author":"Yuriko","year":"1999","journal-title":"Contact Dermatitis"},{"key":"2023100315294772500_llac115-B21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archderm.1974.01630030055015","article-title":"Contact dermatitis from stearyl alcohol and propylene glycol in fluocinonide cream","volume":"109","author":"Shore","year":"1974","journal-title":"Arch Dermatol"},{"key":"2023100315294772500_llac115-B22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-0536.1988.tb02909.x","article-title":"Allergic contact dermatitis from topical steroids","volume":"19","author":"Feldman","year":"1988","journal-title":"Contact Dermatitis"},{"key":"2023100315294772500_llac115-B23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.0105-1873.2003.00169.x","article-title":"Angioedema and dysphagia caused by contact allergy to inhaled budesonide","volume":"49","author":"Pirker","year":"2003","journal-title":"Contact Dermatitis"},{"key":"2023100315294772500_llac115-B24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1684\/ejd.2010.0826","article-title":"Allergic contact dermatitis to inhalation corticosteroids","volume":"20","author":"Baeck","year":"2010","journal-title":"Eur J Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llac115\/48529050\/llac115.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/4\/339\/51836481\/llac115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/4\/339\/51836481\/llac115.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T06:04:39Z","timestamp":1701669879000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/48\/4\/339\/6884077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,12,8]]},"published-print":{"date-parts":[[2023,3,22]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llac115","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4]]},"published":{"date-parts":[[2022,12,8]]}}}